The study was partly based on census data and did not include any information about adults who identify as ethnically Jewish.
Dr Jonathan Boyd, executive director of the Institute for Jewish Policy Research, said the findings were not surprising.
“In general, Jews tend to be well-educated and health conscious so we would expect to see high rates of vaccine uptake. The data show that the challenges tend to lie in more socioeconomically disadvantaged communities,” he said.
Board of Deputies president Marie van der Zyl said the Jewish umbrella group was "very pleased" by the community's high take-up.
"We believe that the very strong messaging from both the rabbinate and communal lay leadership has boosted confidence. The vaccine is a life-saving intervention that will help us return our lives to something resembling normalcy. We urge everyone to take the vaccine when it is offered to them."
